基于肠道菌群探讨中医从脾胃论治代谢相关脂肪性肝病的理论基础
To Explore the Theoretical Basis of Spleen and Stomach Treatment of Metabolic Associated Fatty Liver Disease Based on Intestinal Flora
张荣 1徐强 1窦婧 1王晓波 1王宏峰 1王晓忠1
作者信息
- 1. 新疆维吾尔自治区中医医院,新疆乌鲁木齐 830000
- 折叠
摘要
肠道菌群失调与代谢相关脂肪性肝病(metabolic associated fatty liver disease,MAFLD)的关系密切,调节肠道菌群可以改善MAFLD.从脾胃论治乃中医临床肝病经典治疗方法,临床疗效显著,调节肠道菌群成为从脾胃论治MAFLD新的研究途径.笔者从肠道菌群入手阐述中医从脾胃论治MAFLD的机制,为中医从脾胃论治MAFLD提供现代生物学基础.
Abstract
Metabolic associated fatty liver disease(MAFLD)is closely related to intestinal flora disorders,and regulation of intestinal flora can improve MAFLD.Treating MAFLD by spleen and stomach is a classic method of traditional Chinese medicine with remarkable clinical effect.Regulating intestinal flora has become a new research approach for treating MAFLD by spleen and stomach.The authors elaborate the mechanism of spleen and stomach treatment of MAFLD from intestinal flora in order to provide a modern biological basis for spleen and stomach treatment of MAFLD.
关键词
代谢相关脂肪性肝病/脾胃/肠道菌群Key words
metabolic associated fatty liver disease/the spleen and stomach/intestinal flora引用本文复制引用
出版年
2024
NETL
NSTL
万方数据